Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

Success of Antiretroviral Drugs Creates Need for Increased Education Among High-Risk Groups, Editorial Says

September 15, 2003

The development of new treatments for HIV/AIDS "represents a triumph of medical research" but has also "produced some unexpected pitfalls," including a decline in the use of sterile needles and condoms among injection drug users, a New Orleans Times-Picayune editorial says. Because AIDS is no longer thought to be a "death sentence," some people, such as injection drugs users, have felt less motivated to avoid risky behaviors, the editorial says. For example, researchers from Johns Hopkins University last week said that injection drugs users in Baltimore who think that AIDS is a treatable disease were less likely to use condoms or sterile needles, according to the editorial. Therefore, it is crucial to increase drug rehabilitation programs and "intensify efforts to inform IV drug users in particular of the continuing danger that HIV poses," the editorial says. In addition, public health agencies must communicate that antiretroviral drug regimens are "expensive, inconvenient, hard to follow, full of side effects and, for some patients, ineffective" and that HIV still "remains a terrible burden" for injection drug users or people to whom they might transmit the virus, the editorial concludes (New Orleans Times-Picayune, 9/15).

Back to other news for September 15, 2003


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2003 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
Ask Our Expert, David Fawcett, Ph.D., L.C.S.W., About Substance Use and HIV
More News and Views on Substance Abuse and HIV/AIDS

Tools
 

Advertisement